Amends, repeals, and adds to existing law to establish provisions regarding laboratories.
House Bill 198 revises Idaho law governing clandestine drug laboratory cleanup and expands state oversight of laboratory certification and registration. In the clandestine drug lab portion, the bill updates the purpose and definitions in Chapter 26, Title 6, and creates new statutory sections that require law enforcement to notify the Department of Health and Welfare when a suspected clandestine drug lab is found, place the property on a state site list, and allow delisting only after cleanup verification or lawful demolition. It also sets out detailed sampling procedures, cleanup thresholds for methamphetamine contamination, and reporting requirements for property owners seeking delisting.
The bill also creates two new laboratory regulatory chapters in Title 56. One establishes a drinking water laboratory certification program with annual applications, certification fees, audit authority, reporting deadlines, and mandatory notification of certain contaminant exceedances. The other establishes a quality assurance and registration framework for clinical laboratories, including registration with the department, inspection authority, proficiency testing, recordkeeping, and minimum operational requirements. The bill further authorizes the state laboratory to charge market-rate testing fees and repeals or nullifies several existing administrative rules tied to these programs, replacing them with statutory provisions.
The bill would substantially shift laboratory regulation from administrative rule to statute in several areas, while also tightening and standardizing the cleanup process for properties contaminated by clandestine drug labs. It amends Title 6 to create enforceable cleanup, sampling, certification, and delisting procedures for affected residential properties, and it amends Title 56 to establish statutory certification and registration systems for drinking water and clinical laboratories. It also authorizes new fee collection by the state laboratory and declares multiple IDAPA rules void, meaning affected agencies and regulated entities would have to follow the new statutory framework rather than the repealed rules.
The voting history suggests the bill was broadly supported. It passed the House 67-1 and the Senate 32-2, indicating strong bipartisan approval and little visible opposition in floor votes. No committee transcript was provided, so there is no recorded committee debate to indicate broader public or stakeholder sentiment, but the margin of passage suggests the bill was generally viewed favorably as a technical and regulatory update.
The main points of potential contention are the bill’s detailed cleanup standards, the transfer of authority from administrative rules to statute, and the new fee and inspection powers granted to the Department of Health and Welfare and the state laboratory. Property owners affected by clandestine drug lab designations may be concerned about cleanup costs, mandatory vacancy, and the conditions required for delisting, while laboratories may be sensitive to certification fees, audit requirements, and reporting obligations. The nullification of existing administrative rules may also have drawn attention from regulated entities that preferred the prior rule-based framework or wanted more flexibility in implementation.